AKEBIA THERAPEUTICS INC (AKBA) Institutional Ownership

AKBA is currently held by 1 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $2.55M based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026.

The largest disclosed holder is Renaissance Technologies LLC, which reported ownership valued at approximately $2.55M in its March 31, 2026 13F filing. Based on current market prices and the latest disclosed share count, Renaissance Technologies LLC's AKBA position is now estimated to be worth approximately $1.87M, representing an estimated loss of -26.62% since the filing period.

Major shareholders tracked on this page include Renaissance Technologies LLC, and other prominent asset managers. Collectively, these investors account for approximately 100% of the total disclosed value among the investors covered in this analysis.

This page tracks disclosed ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance to help investors analyze smart money sentiment toward AKEBIA THERAPEUTICS INC (AKBA).

Institutional Ownership Trend

Portfolio quarterInstitutional holdersTotal reported valueTotal shares
Q1 20261$2,548,0481,833,128
Q4 20251$5,784,9443,593,133
Q3 20251$10,790,9453,952,727
Q2 20251$15,267,7144,194,427
Q1 20251$7,691,1884,005,827
Q4 20241$7,264,7013,823,527
Q3 20241$4,907,4963,717,800
Q2 20241$3,993,0963,914,800
Q1 20241$6,6833,652,100
Q4 20231$5,9264,779,383
Q3 20231$3,5973,155,427
Q2 20231$3,0483,330,727

Related AKBA Institutional Insights:

AKBA Institutional Ownership and 13F Activity Q1 2026 | InsiderSet